Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE LA SOURCE : revenue, balance sheet and financial ratios

PHARMACIE DE LA SOURCE is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SOUGE-LE-GANELON (72130), this company of category PME shows in 2022 a revenue of 1.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE DE LA SOURCE (SIREN 509261640)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2017 2016
Umsatz N/C N/C 1 711 758 € N/C N/C N/C N/C N/C N/C
Nettoergebnis 199 665 € 97 626 € 130 849 € 140 162 € 78 050 € 70 149 € 65 201 € 68 215 € 80 719 €
EBITDA N/C N/C 192 852 € N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C 7.6% N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, PHARMACIE DE LA SOURCE generates positive net income of 200 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 81 k€ -> 200 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

199 665 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

4.133%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

90.167%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

9.3%

Entwicklung der Solvenzkennzahlen
PHARMACIE DE LA SOURCE

Positionnement sectoriel

Debt ratio
4.13 2024
2022
2023
2024
Q1: 16.46
Méd: 58.48
Q3: 154.77
Excellent

In 2024, the debt ratio of PHARMACIE DE LA SOURCE (4.13) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
90.17% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Excellent +14 pts über 3 Jahre

In 2024, the financial autonomy of PHARMACIE DE LA SOURCE (90.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.31 years 2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of PHARMACIE DE LA SOURCE (1.31) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 397.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

397.271

Entwicklung der Liquiditätskennzahlen
PHARMACIE DE LA SOURCE

Positionnement sectoriel

Liquidity ratio
397.27 2024
2022
2023
2024
Q1: 129.46
Méd: 182.14
Q3: 260.79
Excellent

In 2024, the liquidity ratio of PHARMACIE DE LA SOURCE (397.27) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.97x 2022
2022
Q1: 0.75x
Méd: 2.51x
Q3: 5.16x
Average

In 2022, the interest coverage of PHARMACIE DE LA SOURCE (1.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE DE LA SOURCE

Positionnement de PHARMACIE DE LA SOURCE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE LA SOURCE is estimated at 2 787 471 € (range 1 941 150€ - 4 170 216€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1941k€ 2787k€ 4170k€
2 787 471 € Range: 1 941 150€ - 4 170 216€
NAF 5 année 2024

Valuation method used

Net Income Multiple
199 665 € × 14.0x = 2 787 471 €
Range: 1 941 151€ - 4 170 216€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA SOURCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA SOURCE

What is the revenue of PHARMACIE DE LA SOURCE ?

The revenue of PHARMACIE DE LA SOURCE in 2022 is 1.7 M€.

Is PHARMACIE DE LA SOURCE profitable?

Yes, PHARMACIE DE LA SOURCE generated a net profit of 200 k€ in 2024.

Where is the headquarters of PHARMACIE DE LA SOURCE ?

The headquarters of PHARMACIE DE LA SOURCE is located in SOUGE-LE-GANELON (72130), in the department Sarthe.

Where to find the tax return of PHARMACIE DE LA SOURCE ?

The tax return of PHARMACIE DE LA SOURCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA SOURCE operate?

PHARMACIE DE LA SOURCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.